中國電力(02380.HK)與控股股東附屬簽訂三份共9,511.16萬人幣承包合同
中國電力(02380.HK)公布,附屬普安電廠與遠達環保工程訂立兩份總承包工程合同,據此遠達環保工程將就普安電廠超低排放脫硫裝置,及脫硝SNCR裝置的改造提供工程、採購及建設服務,代價分別為6,100萬元人民幣(下同)及2,340萬元。
同日,普安電廠及遠達環保催化劑訂立一份承包工程及設計採購合同,遠達環保催化劑將就普安電廠脫硝超低排放新增層催化劑改造提供工程及採購服務,代價為1,071.16萬元。
公司表示,相關承包商為國家電投的間接附屬,國家電投持有公司已發行股本之60.04%並為公司最終控股股東。相關承包合同合併代價為9,511.16萬元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.